| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1159/000081963 |
| P698 | PubMed publication ID | 15627815 |
| P50 | author | Kenneth Maiese | Q85354857 |
| P2093 | author name string | Zhao Zhong Chong | |
| Faqi Li | |||
| P2860 | cites work | Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin | Q48824411 |
| Prevention of nitric oxide-induced neuronal injury through the modulation of independent pathways of programmed cell death. | Q50509399 | ||
| Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. | Q52531761 | ||
| Phagocytic clearance of apoptotic neurons by Microglia/Brain macrophages in vitro: involvement of lectin-, integrin-, and phosphatidylserine-mediated recognition. | Q52970446 | ||
| Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. | Q53218426 | ||
| Nitric-oxide-induced necrosis and apoptosis in PC12 cells mediated by mitochondria. | Q53904848 | ||
| Apoptosis Occurs in a New Model of Thermal Brain Injury | Q56948746 | ||
| Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization | Q58816341 | ||
| Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor | Q22009126 | ||
| The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis | Q22009936 | ||
| Isolation and characterization of genomic and cDNA clones of human erythropoietin | Q24299960 | ||
| Hypoxia-inducible erythropoietin gene expression in human neuroblastoma cells | Q24306966 | ||
| Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c | Q24309066 | ||
| Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis | Q24310597 | ||
| Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade | Q24311006 | ||
| Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase | Q24314333 | ||
| Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway | Q24672316 | ||
| Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin | Q24795283 | ||
| Asialoerythropoietin is not effective in the R6/2 line of Huntington's disease mice | Q24795623 | ||
| Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery | Q27860586 | ||
| Mammalian caspases: structure, activation, substrates, and functions during apoptosis | Q28139429 | ||
| Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction | Q28140805 | ||
| Proteolytic regulation of Forkhead transcription factor FOXO3a by caspase-3-like proteases | Q28189618 | ||
| Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45 | Q28199142 | ||
| Phosphorylation of forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cells | Q28207530 | ||
| PI3 kinase enhancer–Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis | Q28207557 | ||
| Inactivation of caspase-8 on mitochondria of Bcl-xL-expressing MCF7-Fas cells: role for the bifunctional apoptosis regulator protein | Q28208747 | ||
| The CARD domain: a new apoptotic signalling motif | Q28239887 | ||
| Differential MAP kinases activation during semaphorin3A-induced repulsion or apoptosis of neural progenitor cells | Q28256115 | ||
| JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin | Q28260976 | ||
| Death receptors: signaling and modulation | Q28280897 | ||
| Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade | Q28282773 | ||
| The amino-terminal portion of the JAK2 protein kinase is necessary for binding and phosphorylation of the granulocyte-macrophage colony-stimulating factor receptor beta c chain | Q28302928 | ||
| Identification of a novel phosphorylation site, Ser-170, as a regulator of bad pro-apoptotic activity | Q28511401 | ||
| Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death | Q28570235 | ||
| Erythropoietin in the control of red cell production | Q41226769 | ||
| Neurotrophic effect of hematopoietic cytokines on cholinergic and other neurons in vitro. | Q41341699 | ||
| Erythropoietin depresses nitric oxide synthase expression by human endothelial cells | Q41614432 | ||
| A potential role for erythropoietin in focal permanent cerebral ischemia in mice. | Q42473313 | ||
| Proteasomes regulate the duration of erythropoietin receptor activation by controlling down-regulation of cell surface receptors | Q42489065 | ||
| FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons | Q42918105 | ||
| Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts | Q43507062 | ||
| Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. | Q43508981 | ||
| Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture | Q43577442 | ||
| The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study | Q43636269 | ||
| Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia | Q43706820 | ||
| Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. | Q43718523 | ||
| Crosstalk between p38, Hsp25 and Akt in spinal motor neurons after sciatic nerve injury | Q43758935 | ||
| Inhibition of JNK activation through NF-kappaB target genes | Q43802523 | ||
| Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin | Q43886356 | ||
| Nicotinamide modulates mitochondrial membrane potential and cysteine protease activity during cerebral vascular endothelial cell injury | Q43994231 | ||
| Heat shock protein 27 delivered via a herpes simplex virus vector can protect neurons of the hippocampus against kainic-acid-induced cell loss | Q44005958 | ||
| Enhanced glycogen synthase kinase-3beta activity mediates hypoxia-induced apoptosis of vascular smooth muscle cells and is prevented by glucose transport and metabolism | Q44117700 | ||
| Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases | Q44235661 | ||
| The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron | Q44248272 | ||
| NF-kappaB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression | Q44249433 | ||
| Ectopic expression of cell cycle markers in models of induced programmed cell death in dopamine neurons of the rat substantia nigra pars compacta | Q44264442 | ||
| Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8. | Q44313658 | ||
| Apaf-1, Bcl-xL, cytochrome c, and caspase-9 form the critical elements for cerebral vascular protection by erythropoietin | Q44351055 | ||
| Human, nonhuman primate, and rat pancreatic islets express erythropoietin receptors | Q44419297 | ||
| Protection against cisplatin-induced nephrotoxicity by recombinant human erythropoietin | Q44497745 | ||
| Critical role for Akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation | Q44550608 | ||
| Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings. | Q44550966 | ||
| Akt1 protects against inflammatory microglial activation through maintenance of membrane asymmetry and modulation of cysteine protease activity | Q44586804 | ||
| Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels | Q44847078 | ||
| Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells | Q44865870 | ||
| Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice | Q44904989 | ||
| Distinct requirements for p38alpha and c-Jun N-terminal kinase stress-activated protein kinases in different forms of apoptotic neuronal death | Q44932646 | ||
| Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease | Q45299150 | ||
| Single intravenous injection of naked plasmid DNA encoding erythropoietin provides neuroprotection in hypoxia-ischemia rats | Q45872114 | ||
| Nitric oxide metabolism in erythropoietin-induced hypertension: effect of calcium channel blockade. | Q45993079 | ||
| Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats | Q47285421 | ||
| Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietin | Q47409026 | ||
| Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway | Q47612450 | ||
| Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury | Q47849035 | ||
| Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts | Q47951521 | ||
| Blood pressure response to erythropoietin injection in hemodialysis and predialysis patients | Q47989471 | ||
| Measurement and characterization of superoxide generation in microglial cells: evidence for an NADPH oxidase-dependent pathway | Q48027372 | ||
| Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. | Q48144017 | ||
| Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration | Q48163930 | ||
| Protective effect of erythropoietin in neonatal hypoxic ischemia in mice | Q48187195 | ||
| Effects of erythropoietin on neuronal activity | Q48198090 | ||
| Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery | Q48316192 | ||
| Induction of hypoxia inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons | Q48371815 | ||
| Time course of microglia activation and apoptosis in various brain regions after permanent focal cerebral ischemia in mice | Q48411161 | ||
| Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro. | Q48482743 | ||
| Regulated human erythropoietin receptor expression in mouse brain | Q48558987 | ||
| AKT1 drives endothelial cell membrane asymmetry and microglial activation through Bcl-xL and caspase 1, 3, and 9 | Q28572052 | ||
| Akt1 regulates a JNK scaffold during excitotoxic apoptosis | Q28574706 | ||
| Erythropoietin and bone morphogenetic protein 7 mediate ascorbate-induced dopaminergic differentiation from embryonic mesencephalic precursors | Q28575350 | ||
| Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B | Q28638147 | ||
| Purification and characterization of hypoxia-inducible factor 1 | Q28678375 | ||
| Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis | Q29547178 | ||
| Mechanisms of angiogenesis | Q29547485 | ||
| NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation | Q29618715 | ||
| Effect of active oxygen radicals on protein and carbohydrate moieties of recombinant human erythropoietin | Q30428753 | ||
| Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats | Q30480727 | ||
| Erythropoietin modulates intracellular calcium in a human neuroblastoma cell line. | Q30628127 | ||
| Chemical hypoxia-ischemia induces apoptosis in cerebromicrovascular endothelial cells | Q30924971 | ||
| Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway | Q33180653 | ||
| Erythropoietin and VEGF exhibit equal angiogenic potential | Q33184235 | ||
| Serine/threonine protein kinases and apoptosis. | Q33876765 | ||
| Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome | Q33912989 | ||
| Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage | Q34025786 | ||
| Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades | Q34086191 | ||
| Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts | Q34102833 | ||
| Pleckstrin homology domains and the cytoskeleton | Q34120310 | ||
| Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades | Q34125272 | ||
| HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration | Q34133712 | ||
| Apoptosis in Alzheimer's disease--an update | Q34167413 | ||
| Annexin I Is an Endogenous Ligand that Mediates Apoptotic Cell Engulfment | Q34189926 | ||
| Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. | Q34206288 | ||
| Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury | Q34265287 | ||
| Apoptosis-regulating proteins as targets for drug discovery | Q34293102 | ||
| Caspase activation: revisiting the induced proximity model | Q34328287 | ||
| Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death | Q34411455 | ||
| Cell adhesion to phosphatidylserine mediated by a product of growth arrest-specific gene 6. | Q34446220 | ||
| Lubeluzole protects hippocampal neurons from excitotoxicity in vitro and reduces brain damage caused by ischemia | Q34464630 | ||
| Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling | Q34960679 | ||
| Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. | Q35029780 | ||
| Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways | Q35045115 | ||
| Intussusceptive angiogenesis--the alternative to capillary sprouting | Q35049601 | ||
| Angiogenesis and plasticity: role of erythropoietin in vascular systems | Q35067897 | ||
| Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain | Q35136318 | ||
| Erythropoietin: cytoprotection in vascular and neuronal cells | Q35137453 | ||
| Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease | Q35557675 | ||
| Epoetin alfa. Clinical evolution of a pleiotropic cytokine | Q35652564 | ||
| Erythropoietin in cardiovascular diseases. | Q35676092 | ||
| Essential cellular regulatory elements of oxidative stress in early and late phases of apoptosis in the central nervous system | Q35693451 | ||
| Modulating the hypoxia-inducible factor signaling pathway: applications from cardiovascular disease to cancer | Q35699270 | ||
| Protective effect of heat shock proteins in the nervous system | Q36266071 | ||
| Molecular targets to promote central nervous system regeneration | Q36266089 | ||
| FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity | Q36324207 | ||
| Akt regulates cell survival and apoptosis at a postmitochondrial level | Q36342570 | ||
| Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis | Q36371706 | ||
| Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells | Q36380062 | ||
| In vivo evidence that erythropoietin protects neurons from ischemic damage | Q36477827 | ||
| Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration | Q37273048 | ||
| Activation and inhibition of erythropoietin receptor function: role of receptor dimerization | Q38307491 | ||
| Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis | Q38333334 | ||
| The role of carbohydrate in recombinant human erythropoietin | Q38341593 | ||
| Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. | Q38355340 | ||
| Comparative structural study of N-linked oligosaccharides of urinary and recombinant erythropoietins | Q39104192 | ||
| The NAD+ precursor nicotinamide governs neuronal survival during oxidative stress through protein kinase B coupled to FOXO3a and mitochondrial membrane potential | Q40498088 | ||
| Neuroprotection of immortalized hippocampal neurones by brain-derived neurotrophic factor and Raf-1 protein kinase: role of extracellular signal-regulated protein kinase and phosphatidylinositol 3-kinase | Q40580653 | ||
| Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity | Q40581068 | ||
| Bid-mediated mitochondrial pathway is critical to ischemic neuronal apoptosis and focal cerebral ischemia | Q40637230 | ||
| Fractalkine and fractalkine receptors in human neurons and glial cells | Q40717328 | ||
| Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. | Q40767950 | ||
| The cleavage of Akt/protein kinase B by death receptor signaling is an important event in detachment-induced apoptosis | Q40791166 | ||
| cDNA cloning and functional analysis of a truncated STAT5a protein from autonomously growing FDCP-1 cells | Q40832916 | ||
| Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts. | Q40854129 | ||
| Protein kinase C alpha controls erythropoietin receptor signaling | Q40862162 | ||
| Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis | Q40944401 | ||
| Fas antigen modulates ultraviolet B-induced apoptosis of SVHK cells: sequential activation of caspases 8, 3, and 1 in the apoptotic process | Q40948570 | ||
| A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis | Q41008797 | ||
| P433 | issue | 6 | |
| P921 | main subject | erythropoietin | Q218706 |
| P304 | page(s) | 265-289 | |
| P577 | publication date | 2004-11-01 | |
| P1433 | published in | NeuroSignals | Q15758810 |
| P1476 | title | Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways | |
| P478 | volume | 13 |
| Q36944469 | "Sly as a FOXO": new paths with Forkhead signaling in the brain |
| Q35017110 | Age-dependent astroglial vulnerability to hypoxia and glutamate: the role for erythropoietin |
| Q33311719 | Asialoerythropoietin is a strong modulator of angiogenesis by bone-marrow cells |
| Q36002822 | Attempted cell cycle induction in post-mitotic neurons occurs in early and late apoptotic programs through Rb, E2F1, and caspase 3 |
| Q36447198 | Cell Life versus cell longevity: the mysteries surrounding the NAD+ precursor nicotinamide |
| Q36268487 | Cellular response to tissue hypoxia and its involvement in disease progression |
| Q37895012 | Cerebral blood flow alteration in neuroprotection following cerebral ischaemia |
| Q36791150 | Charting a course for erythropoietin in traumatic brain injury. |
| Q45300310 | Contraindications of VEGF-based therapeutic angiogenesis: effects on macrophage density and histology of normal and ischemic brains |
| Q42913267 | Darbepoetin-α treatment enhances glomerular regenerative process in the Thy-1 glomerulonephritis model |
| Q33749358 | Diabetes mellitus: channeling care through cellular discovery |
| Q46802695 | Effect of recombinant human erythropoietin on mitomycin C-induced oxidative stress and genotoxicity in rat kidney and heart tissues |
| Q36266206 | Employing new cellular therapeutic targets for Alzheimer's disease: a change for the better? |
| Q33791317 | Epo is relevant neither for microvascular formation nor for the new formation and maintenance of mice skeletal muscle fibres in both normoxia and hypoxia |
| Q35176135 | Erythropoietin (EPO) in acute kidney injury |
| Q28748456 | Erythropoietin Improves the Survival of Fat Tissue after Its Transplantation in Nude Mice |
| Q34606348 | Erythropoietin after a century of research: younger than ever |
| Q36627295 | Erythropoietin and cerebral vascular protection: role of nitric oxide |
| Q26777878 | Erythropoietin and diabetes mellitus |
| Q28066377 | Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy |
| Q36944477 | Erythropoietin and oxidative stress |
| Q36404124 | Erythropoietin deficiency decreases vascular stability in mice. |
| Q36529533 | Erythropoietin improves neuronal proliferation in dentate gyrus of hippocampal formation in an animal model of Alzheimer's disease |
| Q26863216 | Erythropoietin in Friedreich ataxia |
| Q39671480 | Erythropoietin prevents reactive oxygen species generation and renal tubular cell apoptosis at high glucose level |
| Q36002879 | Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity |
| Q84627462 | Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology |
| Q36740470 | Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies |
| Q26828425 | Erythropoietin: new directions for the nervous system |
| Q83422958 | Fibronectin potentiates topical erythropoietin-induced wound repair in diabetic mice |
| Q36748171 | Mechanistic insights into diabetes mellitus and oxidative stress |
| Q37300232 | Neuroprotective effect of herpes simplex virus-mediated gene transfer of erythropoietin in hyperglycemic dorsal root ganglion neurons |
| Q33717008 | New strategies for Alzheimer's disease and cognitive impairment |
| Q34552287 | Novel avenues of drug discovery and biomarkers for diabetes mellitus |
| Q36556717 | Novel renoprotective actions of erythropoietin: new uses for an old hormone |
| Q36663152 | Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus |
| Q33682262 | Oxidative stress: Biomarkers and novel therapeutic pathways |
| Q26827518 | Oxygen sensing in retinal health and disease |
| Q64318064 | Potential use of transgenic domestic pigs expressing recombinant human erythropoietin in diabetes translation research |
| Q42725836 | Protective effect of recombinant human erythropoietin against cisplatin-induced oxidative stress and nephrotoxicity in rat kidney |
| Q36247651 | Regeneration in the nervous system with erythropoietin |
| Q37295436 | Safety of epoietin beta-quinine drug combination in children with cerebral malaria in Mali |
| Q81860462 | Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease |
| Q35224135 | Systemic administration of erythropoietin inhibits retinopathy in RCS rats |
| Q36836455 | The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury |
| Q36728844 | The Wnt signaling pathway: aging gracefully as a protectionist? |
| Q36002884 | The sirtuin inhibitor nicotinamide enhances neuronal cell survival during acute anoxic injury through AKT, BAD, PARP, and mitochondrial associated "anti-apoptotic" pathways |
| Q37374047 | The vitamin nicotinamide: translating nutrition into clinical care |
| Q45922585 | Topical erythropoietin promotes wound repair in diabetic rats. |
| Q38020966 | Treating patients with schizophrenia deficit with erythropoietin? |
| Q36727444 | Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus |
| Q37182044 | Vascular injury during elevated glucose can be mitigated by erythropoietin and Wnt signaling |
| Q36266255 | Vital elements of the Wnt-Frizzled signaling pathway in the nervous system |
| Q36305544 | Winding through the WNT pathway during cellular development and demise |
| Q36002849 | mGluRI targets microglial activation and selectively prevents neuronal cell engulfment through Akt and caspase dependent pathways |
Search more.